Martin Crook
Direttore/Membro del Consiglio presso Cardior Pharmaceuticals GmbH
Profilo
Martin Crook is currently a Director at Cardior Pharmaceuticals GmbH.
He obtained a doctorate degree from the University of Bristol in 2000, an undergraduate degree from the University of Lancaster in 1995, and a graduate degree from the University of Birmingham in 1996.
Posizioni attive di Martin Crook
| Società | Posizione | Inizio |
|---|---|---|
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Direttore/Membro del Consiglio | - |
Formazione di Martin Crook
| University of Lancaster | Undergraduate Degree |
| University of Birmingham | Graduate Degree |
| University of Bristol | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |
- Borsa valori
- Insiders
- Martin Crook
